We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

Sandbox Reserved 1791

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 28: Line 28:
*When TSHR is not bound to TSH, it is in the inactive state. This is also considered the "down" state because the LRRD is pointing down. When TSH binds to TSHR, steric clashing between TSH and the cell-membrane cause TSHR to take on the active or "up" state. During this transition, the Extracellular domains rotate 55° along an axis. This rotation is caused by conformational changes within the <scene name='95/952720/Hinge_region_spin/1'>Hinge Region</scene>, specifically at the Y279 residue. This residue moves 6 angstroms relative to I486, which is a residue located in the Transmembrane Region <ref name="Faust"/>
*When TSHR is not bound to TSH, it is in the inactive state. This is also considered the "down" state because the LRRD is pointing down. When TSH binds to TSHR, steric clashing between TSH and the cell-membrane cause TSHR to take on the active or "up" state. During this transition, the Extracellular domains rotate 55° along an axis. This rotation is caused by conformational changes within the <scene name='95/952720/Hinge_region_spin/1'>Hinge Region</scene>, specifically at the Y279 residue. This residue moves 6 angstroms relative to I486, which is a residue located in the Transmembrane Region <ref name="Faust"/>
-
== Specific Residues ==
+
== Specific Residues and Interactions==
-
*LYS 58 interacts with Glu 118 on each of the antibodies
+
*There are two <scene name='95/952719/Specific_residues/3'>lysine residues</scene> in the binding pocket of TSHR that are the main contributors to the binding of the antibodies.
-
*LYS 209 interacts with Asp 11 on each of the antibodies
+
*When in the inactive form, Lys 209 does not interact with any residue but Lys 58 has interaction with Glu 118 and this interaction pulls the molecule into the bent position.
*When in the inactive form, Lys 209 does not interact with any residue but Lys 58 has interaction with Glu 118 and this interaction pulls the molecule into the bent position.
*<scene name='95/952719/Specific_residues/1'>LYS Residues</scene>
*<scene name='95/952719/Specific_residues/1'>LYS Residues</scene>
*<scene name='95/952719/Specific_residues/2'>LYS closer look</scene>
*<scene name='95/952719/Specific_residues/2'>LYS closer look</scene>
*<scene name='95/952719/Specific_residues/3'>LYS w/ label</scene>
*<scene name='95/952719/Specific_residues/3'>LYS w/ label</scene>
-
=== Interactions ===
+
*The binding pocket allows a tight interaction with the antibodies. These antibodies make tight interactions with a lot of intermolecular forces at play. <scene name='95/952719/Lock_and_key/1'>Tight interaction</scene>
-
*The binding pocket allows a tight interaction with the antibodies. These antibodies make tight interactions with a lot of IMFs at play. <scene name='95/952719/Lock_and_key/1'>Tight interaction</scene>
+
*LYS 58 interacts with Glu 118 on the antibodies to make a salt bridge interaction
 +
*LYS 209 interacts with Asp 11 on the antibodies to make a salt bridge interaction
 +
*When in the inactive form, Lys 209 does not interact with any residue but Lys 58 has interaction with Glu 118 and this interaction pulls the molecule into the bent position.
*Specifically the two residues make an ionic interaction. The interaction is not close enough to make a hydrogen bond. Instead, the interaction between the Lys residues with the Asp or Glu residues is a salt bridge interaction. This is the main bond that holds these two molecules together. <scene name='95/952719/K---d_interaction/1'>LYS ASP interaction</scene>
*Specifically the two residues make an ionic interaction. The interaction is not close enough to make a hydrogen bond. Instead, the interaction between the Lys residues with the Asp or Glu residues is a salt bridge interaction. This is the main bond that holds these two molecules together. <scene name='95/952719/K---d_interaction/1'>LYS ASP interaction</scene>
*<scene name='95/952719/K---e_interaction/1'>LYS GLU interaction</scene>
*<scene name='95/952719/K---e_interaction/1'>LYS GLU interaction</scene>

Revision as of 04:11, 31 March 2023

This Sandbox is Reserved from February 27 through August 31, 2023 for use in the course CH462 Biochemistry II taught by R. Jeremy Johnson at the Butler University, Indianapolis, USA. This reservation includes Sandbox Reserved 1765 through Sandbox Reserved 1795.
To get started:
  • Click the edit this page tab at the top. Save the page after each step, then edit it again.
  • show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
  • Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

Thyroid Stimulating Hormone Receptor (TSHR)

The Human Thyroid Stimulating Hormone Receptor

Drag the structure with the mouse to rotate

References

  1. Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
  2. Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
  3. 3.0 3.1 3.2 Faust B, Billesbolle CB, Suomivuori CM, Singh I, Zhang K, Hoppe N, Pinto AFM, Diedrich JK, Muftuoglu Y, Szkudlinski MW, Saghatelian A, Dror RO, Cheng Y, Manglik A. Autoantibody mimicry of hormone action at the thyrotropin receptor. Nature. 2022 Aug 8. pii: 10.1038/s41586-022-05159-1. doi:, 10.1038/s41586-022-05159-1. PMID:35940205 doi:http://dx.doi.org/10.1038/s41586-022-05159-1
  4. Duan J, Xu P, Luan X, Ji Y, He X, Song N, Yuan Q, Jin Y, Cheng X, Jiang H, Zheng J, Zhang S, Jiang Y, Xu HE. Hormone- and antibody-mediated activation of the thyrotropin receptor. Nature. 2022 Aug 8. pii: 10.1038/s41586-022-05173-3. doi:, 10.1038/s41586-022-05173-3. PMID:35940204 doi:http://dx.doi.org/10.1038/s41586-022-05173-3

Student Contributions

  • Alex Kem
  • Grace Lane
Personal tools